StockData
Viemed Healthcare, Inc. logo

Viemed Healthcare, Inc. (VMD) stock

VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 17/3010% below fair value
$9.67−0.28 (-2.81%)

Close on Oct 30, 2026Market cap $368.31MP/E 26.9Yield –

Earnings

Viemed Healthcare's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 4, 2026
Q3 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
$78.10M
+23.8% on a year earlier
EPS, Q2 FY2026
$0.07
$0.08 a year earlier
Latest guidance
Raised
Aug 3, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Viemed Healthcare's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 4, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 3, 2026during market hours$78.10M+23.8%$0.07Release
Q1 FY2026ended Mar 31, 2026May 5, 2026during market hours$75.40M+27.6%$0.06Release
Q4 FY2025ended Dec 31, 2025Mar 4, 2026during market hours$76.20M+25.5%$0.14Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025during market hours$71.90M+24.0%$0.09Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025during market hours$63.10M+14.7%$0.08Release
Q1 FY2025ended Mar 31, 2025May 7, 2025during market hours$59.10M+16.8%$0.06Release
Q4 FY2024ended Dec 31, 2024Mar 10, 2025during market hours$60.70M+19.7%$0.10Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024during market hours$58.00M+17.4%$0.10Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024during market hours$55.00M+27.0%$0.04Release
Q1 FY2024ended Mar 31, 2024May 6, 2024during market hours$50.60M+27.8%$0.04Release
Q4 FY2023ended Dec 31, 2023Mar 6, 2024during market hours$50.70M+35.2%$0.09Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Viemed Healthcare's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Net revenueFY2026$314.00M – $320.00M$312.00M – $320.00MRaisedAug 3, 2026
Adjusted EBITDAnon-GAAPFY2026$64.00M – $68.00M$65.00M – $69.00MLoweredAug 3, 2026
Net capital expendituresFY20268.5% – 10%9% – 10.5%LoweredAug 3, 2026

Guidance vs results

The last range Viemed Healthcare gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$271.00M – $273.00M$270.30MΣ4QBelow range
Q4 FY2024Revenue$59.70M – $60.90M$60.70MWithin range
Q3 FY2024Revenue$56.50M – $57.70M$58.00MAbove range
Q2 FY2024Revenue$53.80M – $54.80M$55.00MAbove range
Q1 FY2024Revenue$49.70M – $51.00M$50.60MWithin range
Q4 FY2023Revenue$49.80M – $51.00M$50.70MWithin range
Q3 FY2023Revenue$49.00M – $50.20M$49.40MWithin range
Q2 FY2023Revenue$40.20M – $41.20M$43.30MAbove range
Q1 FY2023Revenue$38.00M – $39.00M$39.60MAbove range
Q4 FY2022Revenue$37.10M – $38.10M$37.50MWithin range
Q3 FY2022Revenue$34.50M – $35.50M$35.80MAbove range
Q2 FY2022Revenue$32.30M – $33.10M$33.30MAbove range

Guidance history

Every forecast Viemed Healthcare put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 3, 2026Net capital expendituresFY20268.5% – 10%Lowered
Aug 3, 2026Adjusted EBITDAFY2026$64.00M – $68.00MLowered
Aug 3, 2026Net revenueFY2026$314.00M – $320.00MRaised
May 5, 2026Net capital expendituresFY20269% – 10.5%Lowered
May 5, 2026Adjusted EBITDAFY2026$65.00M – $69.00MReaffirmed
May 5, 2026Net revenueFY2026$312.00M – $320.00MRaised
Mar 4, 2026Net capital expendituresFY202610% – 11.5%New
Mar 4, 2026Adjusted EBITDAFY2026$65.00M – $69.00MNew
Mar 4, 2026Net revenueFY2026$310.00M – $320.00MNew
Nov 5, 2025Adjusted EBITDAFY2025$60.00M – $62.00MNew
Nov 5, 2025Net RevenueFY2025$271.00M – $273.00MNew
Aug 6, 2025Adjusted EBITDAFY2025$59.00M – $62.00MRaised
Aug 6, 2025Net revenueFY2025$271.00M – $277.00MRaised
May 7, 2025Adjusted EBITDAFY2025$55.00M – $58.00MRaised
May 7, 2025Net revenueFY2025$256.00M – $265.00MRaised
Mar 10, 2025Adjusted EBITDAFY2025$54.00M – $58.00MNew
Mar 10, 2025Net revenueFY2025$254.00M – $265.00MNew
Nov 6, 2024net revenuesQ4 FY2024$59.70M – $60.90MNew
Aug 7, 2024net revenuesQ3 FY2024$56.50M – $57.70MNew
May 6, 2024net revenuesQ2 FY2024$53.80M – $54.80MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Viemed Healthcare filed with the SEC as exhibits to Form 8-K or 6-K

  1. 8-K exhibit EX-99.1
    Update
  2. VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS
    Results
  3. Quarterly results release
    Results
  4. 8-K exhibit EX-99.1
    Update
  5. VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2026 FINANCIAL RESULTS
    Results
  6. Quarterly results release
    Results
  7. 8-K exhibit EX-99.1
    Update
  8. VIEMED HEALTHCARE ANNOUNCES RECORD 2025 FINANCIAL RESULTS
    Results
  9. Financial Supplement NASDAQ: VMD March 4, 2026 1 Fourth Quarter & Full Year 2025
    Results
  10. VIEMED HEALTHCARE ANNOUNCES 2026 SHARE REPURCHASE PROGRAM
    Results
  11. Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD November 2025 VieMed Healthcare Inc. • Investor Presentation
    Update
  12. VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS
    Results
  13. Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care November 5, 2025 1 Third Quarter 2025
    Results
  14. VIEMED HEALTHCARE ANNOUNCES COMPLETION OF SHARE REPURCHASE PROGRAM
    Update
  15. VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS
    Results